Showing results (101-110 of 444) with videos related to

Sort By:
Pageof 45
Chest|April 23, 2016
Management of Myositis-Related Interstitial Lung DiseaseJulie Morisset, Cheilonda Johnson, Eric Rich, et al.
Chest|March 16, 2007
Sildenafil improves walk distance in idiopathic pulmonary fibrosisHarold R Collard, Kevin J Anstrom, Marvin I Schwarz, et al.
Expert Opinion on Pharmacotherapy|January 13, 2018
Nintedanib for the treatment of idiopathic pulmonary fibrosisFrancesco Varone, Giacomo Sgalla, Bruno Iovene, et al.
Annals of the American Thoracic Society|May 22, 2018
Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-AnalysisSabina A Guler, Kina Ellison, Mohmmed Algamdi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study ProtocolLuca Richeldi, Alessio Piraino, Francesco Macagno, et al.
The American Journal of the Medical Sciences|April 24, 2019
Current and Future Idiopathic Pulmonary Fibrosis TherapyLuca Richeldi, Fabiana Baldi, Giuliana Pasciuto, et al.
Respiratory Research|April 12, 2019
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trialsMichael Kreuter, Harald Koegler, Matthias Trampisch, et al.
Multidisciplinary Respiratory Medicine|November 14, 2012
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesPaolo Spagnolo, Roberto Tonelli, Elisabetta Cocconcelli, et al.
Chest|January 21, 2020
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity PneumonitisHayley Barnes, Julie Morisset, Philip Molyneaux, et al.
Diabetes Research and Clinical Practice|March 23, 2012
Reduced lung diffusion capacity in type 2 diabetes is independent of heart failureOana L Klein, Madeline Jones, Jungwha Lee, et al.
Pageof 45